{"id":43499,"date":"2022-05-21T11:52:39","date_gmt":"2022-05-21T15:52:39","guid":{"rendered":"https:\/\/sciencebusiness.technewslit.com\/?p=43499"},"modified":"2022-05-21T11:52:39","modified_gmt":"2022-05-21T15:52:39","slug":"infographic-100-promising-ai-companies","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=43499","title":{"rendered":"Infographic – 100 Promising AI Companies"},"content":{"rendered":"
\"CB<\/a>
Click on image for full-size view (CB Insights)<\/figcaption><\/figure>\n

21 May 2022. Artificial intelligence, or A.I., is underpinning more and more of our daily work and life in general. And A.I. algorithms are becoming a key part of a scientist’s toolkit for analytics, diagnostics, and drug discovery, as we report almost daily on Science & Enterprise. As a result, A.I. is attracting a good deal of business interest, seen in more new enterprises and investment money worldwide for applications across a range of industries and A.I. development tools.<\/p>\n

The technology intelligence company CB Insights<\/a> now compiles an annual list of new companies creating A.I. applications and tools, with the 2022 collection<\/a> published this week. CB Insights uses a number of criteria to identify these 100 start-ups, including R&D activity, market potential, and technological novelty, with the list broken down into cross-industry applications, industry-specific applications, and development tools.<\/p>\n

Of the three main categories, specific A.I. industry applications are the largest category, making up 43 of the 100 new companies in the CB Insights list. Nearly a quarter of those industry applications, 10 of 43, are in health care, including Insilico Medicine<\/a>, based in Hong Kong. Science & Enterprise has reported several times on Insilico Medicine, which first began offering A.I. analytics as a service for drug discovery, and now discovers and develops<\/a> its own treatments.<\/p>\n

CB Insights says the 100 companies overall raised some $12 billion from 650 investors since 2017, with 39 of the companies still in seed or first-round venture financing. In the links below are Science & Enterprise stories describing venture funds created this year seeking to finance A.I. advances or applications.<\/p>\n

More from Science & Enterprise:<\/p>\n